Ergomed plc (LSE: ERGO) (“Ergomed” or the “Company”), a company focused on providing specialised services to the pharmaceutical industry, today announces the acquisition of MS Clinical Services, LLC (“MedSource”), a specialised clinical research organisation (CRO) based in Houston, Texas, USA. MedSource is a full-service CRO with a focus on complex diseases and study designs. MedSource delivers high-quality clinical trials specialising in oncology and rare disease. With over 20 years’ experience, MedSource has participated in more than 200 oncology and rare disease clinical trials.
Read the full article: Ergomed Acquires MedSource, a US-Based Specialist Oncology and Rare Disease CRO //
Source: https://www.globenewswire.com/news-release/2020/12/14/2144360/0/en/Ergomed-acquires-MedSource-a-US-based-specialist-oncology-and-rare-disease-CRO.html